This a patented screening & monitoring tool using the Swaasa AI Platform. This technology is based on audiometric analysis of cough sounds and other symptoms. This is a powerful alternative to antibody testing for population monitoring/ surveillance. Unlike other forms of surveillance and testing, Swaasa provides a continuing longitudinal view as opposed to status at a specific point in time. Relative to other options, this technology is cheaper by a factor of nearly 100. Citizens can administer the diagnostic themselves.
What pain-point does it solve?
1. Analysing the symptoms of self isolating patients.
2. Reporting of the conditions of self isolating patients and cured COVID-19 patients.
3. This can help in staying at home and visiting the hospital only when the risk score is high.
Who are the ideal users of our technology?
Asymptomatic patients, offices, public health officials
How does it solve the pain-point?
The software analyzes the symptoms using ML and AI with algorithms that have been developed with medical expertise to track and control patients only by doing an audiometric examination and delivering a COVID-19 risk score.
Local health authorities are notified if the score is high and dangerous. This helps to track as well as reduce the unnecessary trip to the hospital.
What makes us stand apart from competitors ?
A patented ML model based on respiratory sounds that allows Salcit to bring the functionality of Spirometry unbounded by time, space, specialized equipment and trained professionals. This core ability allows the solution to be rapidly deployed at scale to screen and surveil. Swaasa is now enhanced and re-purposed for COVID 19 screening and monitoring. The solution has two parts an mobile application called kAs and a dashboard for health practitioners.
The story of our successful deployments
If you have any queries, please don’t hesitate to get in touch.
We are looking forward to hearing from you.